Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Rev. bras. cir. plást ; 34(3): 368-377, jul.-sep. 2019. ilus, tab
Article in English, Portuguese | LILACS | ID: biblio-1047157

ABSTRACT

Introdução: Com o objetivo de obter lipoenxerto autógeno e injetável de tecido ressecado em dermolipectomias, este estudo propõe um novo método para colheita e processamento do tecido adiposo, através de um dispositivo fragmentador específico. O principal objetivo foi estabelecer uma análise comparativa das características de qualidade e viabilidade do novo lipofragmentado em relação ao já conhecido lipoaspirado, amplamente aceito como fonte viável de lipoenxerto. Ensaios in vivo e in vitro foram delineados para avaliar o comportamento biológico das amostras, a fim de orientar novos e possíveis estudos em humanos com aplicações clínicas. Métodos: Uma paciente pós-bariátrica que foi submetida a dermolipectomia abdominal teve sua peça cirúrgica ressecada e dividida em quatro partes que foram submetidas a Lipoaspiração e Lipofragmentação, sem e com infiltração prévia. Todas as amostras foram submetidas a centrifugação e então distribuídas para os ensaios que envolveram avaliação histológica, imunohistoquímica, citometria de fluxo, cultura celular e ainda a injeção de xenoenxerto no dorso de 10 ratos Wistar, retirados após seis semanas para avaliação de massa, volume e características histológicas. Resultados: As amostras de gordura fragmentada, seca e infiltrada, mostraram características estruturais e comportamento biológico semelhantes aos das amostras de lipoaspirado. Conclusões: A fragmentação da gordura transformou o tecido celular subcutâneo das dermolipectomias em uma nova variante de lipoenxerto injetável e viável, com características biológicas semelhantes àquelas do lipoaspirado tradicional. Embora ainda preliminares, nossos resultados embasam a realização de novas investigações buscando otimizar a técnica com vistas ao aprimoramento da enxertia gordurosa e suas possíveis aplicações na medicina regenerativa.


Introduction: Aiming to obtain autogenous and injectable lipografts from resected tissues in dermolipectomies, this study proposes a new method for harvesting and processing adipose tissue through a specific fragmenting device. The main objective was to establish a comparative analysis of the quality and viability characteristics of the new lipofragmentation technique and those of the well-known liposuction technique, widely accepted as a viable source of fat grafting. In vivo and in vitro assays were designed to evaluate the biological behavior of the samples to guide new and possible human studies with clinical applications. Methods: A post-bariatric patient who underwent abdominal dermolipectomy had her surgical specimen resected, which was divided into four parts that underwent liposuction and lipofragmentation, with and without prior infiltration. All samples were centrifuged and distributed for assays with assessments involving histological analysis, immunohistochemistry, flow cytometry, cell culture, and xenograft injection on the back of 10 Wistar rats, which was evaluated after six weeks for mass, volume, and histological features. Results: The structural characteristics and biological behaviors of fragmented, dry, and infiltrated fat samples were similar to those of liposuction samples. Conclusions: Fat fragmentation transformed the subcutaneous cellular tissue of dermolipectomies into a new, viable injectable lipograft variant, with biological characteristics similar to those of traditional liposuction. Although still preliminary, our results support further investigations to optimize the technique and improve fat grafting and its possible applications in regenerative medicine.


Subject(s)
Humans , Female , Adult , Rats , History, 21st Century , Specimen Handling , Surgery, Plastic , Transplantation, Autologous , Bioprosthesis , Adipose Tissue , Plastic Surgery Procedures , Graft Survival , Specimen Handling/methods , Surgery, Plastic/methods , Transplantation, Autologous/methods , Bioprosthesis/standards , Adipose Tissue/anatomy & histology , Plastic Surgery Procedures/methods
2.
Acta cir. bras ; 34(8): e201900806, 2019. tab, graf
Article in English | LILACS | ID: biblio-1038123

ABSTRACT

Abstract Purpose To assess Cyclosporine A (CsA) therapy at an intraperitoneal dose of 15 mg.kg -1 in a rodent model of non-septic renal ischemia. Methods Twenty male Wistar rats were randomized to receive CsA therapy or none therapy before undergoing 30 minutes of renal ischemia followed by reperfusion. Additionally, 10 rats were randomized to undergo the same surgical procedure of the aforementioned animals with neither ischemia nor CsA therapy. Twelve hours after kidney ischemia, the left kidneys were evaluated for histological injury according to Park's criteria. Serum creatinine (Cr), urea nitrogen (Ur) and sodium levels were obtained at different times of the experimental protocol. Results Rodents in the CsA group showed negative results (p<0.05) in serum variables (Cr: 0.41±0.05mg/dL vs . 4.17±1.25mg/dL; Ur: 40.90±3.98mg/dL vs . 187.70±22.93mg/dL) even the non CsA or control group (Cr: 0.35±0.07mg/dL vs . 3.80±1.20mg/dL; Ur: 40.10±4.70mg/dL vs . 184.50±49.80mg/dL). The negative results were also verified in histological evaluation, CsA group had 50% in the very severe grade of lesion, 10% in the severe and 40% in the moderate to severe whereas the control group had 90% in the very severe grade. Conclusion CsA was incapable of preventing the deleterious effects of ischemia-reperfusion injury in rat kidneys.


Subject(s)
Animals , Male , Rats , Reperfusion Injury/drug therapy , Cyclosporine/pharmacology , Immunosuppressive Agents/pharmacokinetics , Kidney/blood supply , Sodium/blood , Urea/blood , Reperfusion Injury/pathology , Rats, Wistar , Creatinine/blood , Disease Models, Animal , Ischemia/prevention & control , Kidney/drug effects
3.
Autops. Case Rep ; 8(1): e2018001, Jan.-Mar. 2018. tab, ilus
Article in English | LILACS | ID: biblio-905418

ABSTRACT

Histiocytic sarcoma (HS) is a rare malignant neoplasia of hematopoietic origin and unknown etiology. We studied three patients with histiocytic sarcoma reviewing the morphological and immunohistochemical aspects. We evaluated in particular, if apoptosis may be unbalanced in this disease. All cases have morphological and immunohistochemical features consistent with the diagnosis of histiocytic sarcoma. The markers CD163, CD68, vimentin, lysozyme, and S-100 were positive in all cases. Similarly, the three samples were positive for Fas-ligand and Caspase-3. It is well-known that neoplasms may induce increased levels of Fas-ligand with the blockade of the apoptosis process. In the context of HS, the increased Fas-ligand expression represents a new area for research. Indeed, it is linked to proinflammatory stimulus and, maybe with the association of an infection.


Subject(s)
Humans , Male , Female , Adult , Aged , Histiocytic Sarcoma/etiology , Apoptosis , Caspase 3 , Fas Ligand Protein , Histiocytic Sarcoma/diagnosis , Immunohistochemistry
4.
Acta cir. bras ; 30(4): 270-276, 04/2015. tab, graf
Article in English | LILACS | ID: lil-744283

ABSTRACT

PURPOSE: To evaluate the effect of parecoxib (an NSAID) on renal function by measuring plasma NGAL (serum neutrophil gelatinase-associated lipocalin) levels in an induced-ischemia rat model. METHODS: Forty male Wistar rats were randomly assigned to one of four groups: Ischemia (I), Ischemia/parecoxib (IP), No-ischemia (NI), and No-ischemia/parecoxib (NIP). Body weight, mean arterial pressure, heart rate, body temperature, NGAL levels, and renal histology were compared across groups. RESULTS: The Ischemia (I) group, which did not receive parecoxib, showed the highest NGAL levels (p=0.001), while the IP group, which received the medication, had NGAL levels similar to those of the non-ischemic (NI and NIP) groups. CONCLUSION: Parecoxib resulted in renal protection in this experimental model. .


Subject(s)
Animals , Male , Acute Kidney Injury/prevention & control , /therapeutic use , Disease Models, Animal , Isoxazoles/therapeutic use , Kidney/blood supply , Reperfusion Injury/prevention & control , Acute-Phase Proteins , Acute Kidney Injury/pathology , Biomarkers/blood , Blood Pressure/drug effects , Enzyme-Linked Immunosorbent Assay , Kidney/pathology , Lipocalins/blood , Prospective Studies , Proto-Oncogene Proteins/blood , Random Allocation , Rats, Wistar , Reproducibility of Results , Severity of Illness Index , Time Factors , Treatment Outcome
5.
Acta cir. bras ; 30(3): 178-185, 03/2015. tab, graf
Article in English | LILACS | ID: lil-741036

ABSTRACT

PURPOSE: To investigate the effects of exposure to cigarette and alcohol on immunohistochemical disorders caused by these attacks to respiratory system of rats. METHODS: Sixty male Wistar rats in four groups: control, cigarette smoke, alcohol and cigarette smoke + alcohol during 260 days. Immunohistochemistry was performed by researching survivin and protein P53 expressions and apoptotic index in parenchymal lung and trachea using TUNEL technique. RESULTS: There was body growth impairment in all experimental groups. Both smoker groups animals had higher trachea survivin expression and bronchial higher apoptotic index. The trachea apoptotic index was also higher in the cigarette smoke group as well as in the alveoli in the cigarette smoke + alcohol group. The three experimental groups showed negative immunoexpression for P53. CONCLUSIONS: this model resulted in immunohistochemical changes caused mainly by exposure to cigarette smoke. There was a synergistic action between alcohol and tobacco in the growth impairment in animals as well as in the cellular apoptotic index. The positive immunoexpression for tracheal survivin in animals from both groups exposed to tobacco smoke and associated with a negative P53 immunoexpression suggests that despite the aggression, carcinogenesis has not happened yet. In addition, the bronchial higher apoptotic index in smokers may be responsible for emphysema. .


Subject(s)
Academic Medical Centers/statistics & numerical data , Career Choice , Faculty, Medical/statistics & numerical data , Internship and Residency , Internship and Residency/statistics & numerical data , Radiology/education , Radiology
6.
Acta cir. bras ; 29(8): 515-521, 08/2014. tab, graf
Article in English | LILACS | ID: lil-719184

ABSTRACT

PURPOSE: To investigate whether allopurinol exerts a protective effect on kidneys by measuring new kidney injury biomarkers (NGALp, NGALu, KIM 1 and IL 18) and analysing the renal function and histology in uninephrectomised rats subjected to ischaemia-reperfusion injury. METHODS: Thirty two Wistar rats were randomly allocated to four groups: Sham (S): laparotomy; Control (C): laparotomy and ischaemia-reperfusion in the left kidney; Control Allopurinol (CA): laparotomy and allopurinol at a dose of 100mg·kg 1·d 1; and Allopurinol (A): laparotomy ischaemia-reperfusion in the left kidney and allopurinol at a dose of 100mg·kg 1·d 1. The NGALp, NGALu, KIM 1, IL 18 and creatinine levels and the kidney histology were analysed. The significance level was established as p<0.05. RESULTS: Creatinine level increased in all the groups, with A ≈ C > S ≈ CA. The NGALp, NGALu and IL 18 levels exhibited similar behaviour in all the groups. KIM 1 was higher in group A than C and showed intermediate values in groups S and CA. Severity of injury in the left kidney was greater in groups C and A compared to S and CA. CONCLUSION: Allopurinol did not exert protective or damaging effects on the kidneys of rats subjected to ischaemia-reperfusion injury. .


Subject(s)
Animals , Male , Acute-Phase Proteins/analysis , Allopurinol/pharmacology , Antimetabolites/pharmacology , /analysis , Ischemia/drug therapy , Kidney/blood supply , Kidney/drug effects , Lipocalins/analysis , Proto-Oncogene Proteins/analysis , Acute-Phase Proteins/drug effects , Biomarkers/blood , Creatinine/blood , Kidney/pathology , Lipocalins/drug effects , Proto-Oncogene Proteins/drug effects , Random Allocation , Rats, Wistar , Reperfusion Injury/drug therapy , Reperfusion Injury/pathology
7.
Acta cir. bras ; 28(9): 632-640, Sept. 2013. ilus, tab
Article in English | LILACS | ID: lil-684436

ABSTRACT

PURPOSE: To investigate and compare the biocompatibility of two types of Ferrara intracorneal ring segment: with and without chondroitin sulfate coating by clinical and histopathological evaluation. METHODS: A randomized experimental study was carried out on thirty right-eye corneas from 30 Norfolk albino rabbits allocated into two experimental groups: Group G1 - implanted with Ferrara intracorneal ring segment without coating (FICRS) and Group G2 - implanted with Ferrara intracorneal ring segment with chondroitin sulfate coating (FICRS-CS). Left eyes formed the control group. Clinical parameters analyzed were: presence of edema, vascularization, infection and ring extrusion one, 30, and 60 days after surgery. Histopathological parameters analyzed were: number of corneal epithelial layers over and adjacent to the ring, presence of spongiosis, hydropic degeneration, basement membrane thinning, inflammatory cells, neovascularization and pseudocapsule formation. RESULTS: At clinical examination 60 days after implant, edema, vascularization and extrusion were observed respectively in 20%, 26.7%, 6.7% of FICRS corneas and in 6.7%, 6.7%, and 0% of FICRS-CS corneas. Histopathological evaluation showed epithelial-layer reduction from 5 (5;6) to 3 (3;3) with FICRS and from 5 (5;5) to 4 (3;5) with FICRS-CS in the region over the ring. Epithelial spongiosis, hydropic degeneration, and basement membrane thinning were present in 69.2%, 53.8%, and 69.2% of FICRS and in 73.3%, 73.3%, and 46.7% with FICRS-CS, respectively. Vascularization was present in 38.5% of FICRS and 13.3% with FICRS-CS, inflammatory cells in 75% of FICRS and 33.3% with FICRS-CS, and pseudocapsule in 66.7% of FICRS and 93.3% with FICRS-CS. Giant cells occurred only in the FICRS-CS group (20%). CONCLUSION: Ferrara intracorneal rings coated with chondroitin sulfate (FICRS-CS) caused lower frequency of clinical and histopathological alterations than Ferrara intracorneal rings without the coating (FICRS), demonstrating higher biocompatibility of the FICRS-CS.


Subject(s)
Animals , Female , Rabbits , Biocompatible Materials/therapeutic use , Chondroitin Sulfates/therapeutic use , Corneal Stroma/surgery , Prostheses and Implants , Prosthesis Implantation/methods , Corneal Diseases/surgery , Corneal Stroma/anatomy & histology , Materials Testing , Prosthesis Fitting , Random Allocation , Reference Values , Reproducibility of Results , Time Factors , Treatment Outcome
8.
Acta cir. bras ; 28(3): 195-201, Mar. 2013. ilus, tab
Article in English | LILACS | ID: lil-667930

ABSTRACT

PURPOSE: To study the bone viability of a vascularized galea and periosteum flap filled with bone fragments, as a substitute of the bone graft in facial reconstructive surgery. METHODS: Forty rabbits were studied, and divided in two groups. One had a simple galea and periosteum flap done and the other had the same flap done and filled with bone fragments of the calvaria. The bone formation was evaluated by radiographies, macroscopic and microscopic analysis. RESULTS: The bone neoformation in both groups with differences in bone morphology and structure especially at histological analysis. CONCLUSION: This study demonstrated osseous formation in both groups of galea and periosteum flaps, with and without bone fragments.


Subject(s)
Animals , Male , Rabbits , Bone Substitutes , Periosteum/transplantation , Plastic Surgery Procedures/methods , Surgical Flaps , Bone Regeneration , Bone Transplantation/methods , Observer Variation , Osteogenesis , Reproducibility of Results , Time Factors , Treatment Outcome
9.
Acta cir. bras ; 28(1): 5-9, jan. 2013. ilus, tab
Article in English | LILACS | ID: lil-662341

ABSTRACT

PURPOSE: To compare fluid replacement therapy with Hydroxyethyl starch 6% (HES) versus Ringer's lactate (RL) in a rodent model of non-septic renal ischemia. METHODS: Forty male Wistar rats were randomized to receive HES 2 ml.kg-1.hr-1or RL 5 ml. kg-1.hr-1 that underwent 30 minutes of renal ischemia followed by reperfusion. Twelve hours after kidney ischemia, the kidneys were evaluated for histological changes. Serum NGAL levels were obtained at different times of the experimental protocol. RESULTS: Rodents in the HES group had a median (IQR) grade of renal injury 3 (3 to 5) compared to 2 (2 to 4) in the RL group (p=0.03). NGAL levels were not associated with the severity of kidney injury. CONCLUSION: Hydroxyethyl starch administration caused more kidney injury than Ringer's lactate in a non-infectious model of renal hypoperfusion.


Subject(s)
Animals , Male , Rats , Acute Kidney Injury/therapy , Hydroxyethyl Starch Derivatives/therapeutic use , Ischemia/therapy , Isotonic Solutions/therapeutic use , Kidney/blood supply , Plasma Substitutes/therapeutic use , Acute-Phase Proteins , Acute Kidney Injury/pathology , Fluid Therapy/methods , Hemodynamics , Ischemia/pathology , Kidney/pathology , Lipocalins/blood , Oncogene Proteins/blood , Random Allocation , Rats, Wistar , Reproducibility of Results , Time Factors , Treatment Outcome
10.
Rev. bras. reumatol ; 48(4): 249-252, jul.-ago. 2008. ilus
Article in Portuguese | LILACS | ID: lil-496415

ABSTRACT

A hemofagocitose reativa ou síndrome de ativação macrofágica (SAM) é uma complicação das doenças inflamatórias sistêmicas, causada por expansão de células T e macrófagos, com produção maciça de citocinas pró-inflamatórias, ocorrendo mais freqüentemente na artrite idiopática juvenil sistêmica e raramente no lúpus eritematoso sistêmico juvenil (LESJ). OBJETIVO: Relatar um caso de LESJ que evoluiu com SAM precipitada por infecção e infarto esplênico, com desfecho fatal. RELATO DE CASO: Uma menina de 7 anos, com diagnóstico de LESJ desde os 5 anos, evoluiu com artrite em atividade, alopecia intensa, citopenias, cefaléia, infecções respiratórias recorrentes e elevação intermitente de transaminases. Os anticorpos anti-DNA e anticardiolipina IgG e IgM foram identificados e a biópsia renal evidenciou glomerulonefrite lúpica de classe III. A paciente foi tratada com pulso de metilprednisolona, prednisona, azatioprina e hidroxicloroquina. Após dois anos, na vigência de pneumonia apresentou abdome agudo e convulsões, evoluindo para o choque hemorrágico fatal após esplenectomia, que evidenciou infarto esplênico e infiltração maciça por macrófagos hemofagocíticos CD163+. CONCLUSÃO: A revisão do desfecho sugere a SAM precipitada por infecção e sobreposta a atividade inflamatória do lúpus com febre persistente, citopenias, disfunção hepática, hepatomegalia e esplenomegalia, como efeitos do excesso de produção de citocinas. Os anticorpos anticardiolipina podem ter tido papel precipitante na coagulopatia, que resultou infarto esplênico e choque hemorrágico.


Reactive haemophagocytosis or macrophage activation syndrome (MAS) is a complication of systemic inflammatory disorders, caused by expansion of T cells and haemophagocytic macrophages, with cytokine overproduction. It has been described most often in systemic juvenile idiopathic arthritis and rarely in juvenile systemic lupus erythematosus (JSLE). OBJECTIVE: To report a JSLE case who developed MAS in association with spleen infarct triggered by infection, with fatal outcome. CASE REPORT: A 7-year old-girl diagnosed with lupus since age 5-y developed several episodes of arthritis flare, cytopenias, severe alopecia, headaches and recurrent episodes of respiratory infections with intermittently increased serum transaminases. Anti-DNA and anti-cardiolipin IgG and IgM were identified and Class III lupus glomerulonephritis was diagnosed by renal biopsy. The patient was treated with methylprednisolone pulses, prednisone, azatioprine and hydroxychloroquine. Last admitted due to pneumonia, she evolved into abdominal crisis and seizures, undergoing splenectomy and evolving into haemorragic shock with fatal outcome. A spleen infarct was found and anti-CD163 antibodies staining disclosed intense haemophagocytic macrophage infiltration. CONCLUSION: This outcome suggests infection-triggered MAS overlapping lupus flare with persistent fever, cytopenia, liver dysfunction, hepatomegaly and splenomegaly as cytokine excess driven effect. Anti-cardiolipin antibodies may also had a coagulopathy precipiting role.


Subject(s)
Humans , Female , Child , Lupus Erythematosus, Systemic , Lupus Erythematosus, Systemic/complications , Macrophage Activation , Syndrome
11.
Botucatu; s.n; 2006. 85 p. graf, tab, ilus.
Thesis in Portuguese | LILACS | ID: lil-468366

ABSTRACT

Histórico: Linfoma de Grandes Células B Difuso (LGCBD) é uma entidade clínica e morfológica, definida nas classificações REAL e OMS como tipo mais comum de linfoma não Hodgkin em adultos. A busca de marcadores biológicos que determinem subgrupos de pacientes com evolução favorável é incessante. A p53 é muita estudada em associação com a manutenção da integridade celular submetidas ao stress, enquanto a super expressão Survivina tem merecido atenção especial nas malignidades linfóides. Objetivo: A imuno expressão Survivina e da p53 foi investigada de maneira retrospectiva, utilizando imunohistoquímica nos biópsias de diagnóstico de LGCBD, buscando o potencial prognóstico destas Ímuno expressões. Casuística: 75 pacientes com LGCBD, oriunda do serviço de Onco Hematologia, CEPON, SC, sul do Brasil, foram acompanhados de 1997 á 2001. Estima-se que neste período mais de 90% dos pacientes utilizou este serviço de alta complexidade, portanto, a amostragem escolhida serve como um estudo de sobrevida populacional. Resultados: A expressão da Survivina foi observada em 44 % dos pacientes e P53 em 41%. Observou-se que os pacientes Survivina positivos não entravam em remissão completa (p menor que 0,0001) e o tempo de sobrevida não ultrapassou 540 dias. Nos casos p53 positivos e negativos, observou-se uma distribuição equilibrada (p maior que 0.05) Discussão: A imuno expressão do Survivina predizia uma menor sobrevida, independente de qualquer fator prognóstico bem estabelecido. Estes resultados demonstram a importância da expressão das proteínas sinalizadoras da apoptose como alvos terapêuticos nos LGCBD e como indicadores de subgrupos de pacientes que possam vir a receber os mais atuais esquemas quimioterápicos, assim, aumentando chances de remissão e sobrevida...


Subject(s)
Humans , Male , Female , Adolescent , Adult , Aged , Lymphoma, Large B-Cell, Diffuse , Lymphoma, Non-Hodgkin , Survival
12.
Rev. bras. oftalmol ; 59(4): 263-267, abr. 2000. ilus
Article in Portuguese | LILACS | ID: lil-309855

ABSTRACT

Os linfomas primários da órbita são raros e somente em 1 por cento dos casos de linfoma com envolvimento sistêmico o acometimento orbital é observado. O presente trabalho foi realizado no Serviço de Oftalmologia do Hospital Regional Homero de Miranda Gomes, em São José - SC e no Hemocentro e Centro de Pesquisas Oncológicas de Santa Catarina, em Florianópolis - SC. Este artigo relata o caso de um paciente com proptose, cujo diagnóstico histopatológico foi de linfoma primário de órbita. Após realizado o estadiamento, opta-se por uma modalidade de tratamento, que baseia-se na radioterapia e/ou quimioterapia. O prognóstico nos casos de baixo grau tende a ser melhor do que naqueles de grau intermediário e alto.


Subject(s)
Humans , Male , Aged , Lymphoma, Non-Hodgkin/diagnosis , Orbit/pathology , Biopsy , Tomography
SELECTION OF CITATIONS
SEARCH DETAIL